You just read:

Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer

News provided by

Taiho Pharmaceutical Co., Ltd.

Apr 01, 2016, 03:00 ET